Annual Drug Patent Expirations for ICLUSIG
Iclusig is a drug marketed by Ariad and is included in one NDA. There are three patents protecting this drug.
This drug has seventy-eight patent family members in twenty-three countries.
The generic ingredient in ICLUSIG is ponatinib hydrochloride. Additional details are available on the ponatinib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
